These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24890139)

  • 1. Comparison of VEGF gene silencing efficiencies of chitosan and protamine complexes containing shRNA.
    Erdem-Çakmak F; Özbaş-Turan S; Şalva E; Akbuğa J
    Cell Biol Int; 2014 Nov; 38(11):1260-70. PubMed ID: 24890139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of ternary nanoplexes for efficient small interfering RNA delivery.
    Şalva E; Turan SÖ; Akbuğa J
    Biol Pharm Bull; 2013; 36(12):1907-14. PubMed ID: 24432377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular weight chitosan/vascular endothelial growth factor short hairpin RNA for the treatment of hepatocellular carcinoma.
    Huang Z; Dong L; Chen J; Gao F; Zhang Z; Chen J; Zhang J
    Life Sci; 2012 Dec; 91(23-24):1207-15. PubMed ID: 23044224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the therapeutic efficacy of codelivery of psiRNA-vascular endothelial growth factor and pIL-4 into chitosan nanoparticles in the breast tumor model.
    Şalva E; Turan SO; Kabasakal L; Alan S; Özkan N; Eren F; Akbuğa J
    J Pharm Sci; 2014 Mar; 103(3):785-95. PubMed ID: 24357345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1α and VEGF.
    Şalva E; Turan SÖ; Eren F; Akbuğa J
    Int J Pharm; 2015 Jan; 478(1):147-154. PubMed ID: 25445537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro silencing effect of chitosan nanoplexes containing siRNA expressing vector targeting VEGF in breast cancer cell lines.
    Salva E; Akbuğa J
    Pharmazie; 2010 Dec; 65(12):896-902. PubMed ID: 21284259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan/short hairpin RNA complexes for vascular endothelial growth factor suppression invasive breast carcinoma.
    Salva E; Kabasakal L; Eren F; Cakalağaoğlu F; Ozkan N; Akbuğa J
    Oligonucleotides; 2010 Aug; 20(4):183-90. PubMed ID: 20707740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quaternary complexes composed of plasmid DNA/protamine/fish sperm DNA/stearic acid grafted chitosan oligosaccharide micelles for gene delivery.
    Du YZ; Lu P; Yuan H; Zhou JP; Hu FQ
    Int J Biol Macromol; 2011 Jan; 48(1):153-9. PubMed ID: 21035503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocomposite-siRNA approach for down-regulation of VEGF and its receptor in myeloid leukemia cells.
    Wang L; Zhang WJ; Xiu B; Ding Y; Li P; Ye WD; Zhu Q; Liang AB
    Int J Biol Macromol; 2014 Feb; 63():49-55. PubMed ID: 24183807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
    Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R
    Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery.
    He SN; Li YL; Yan JJ; Zhang W; Du YZ; Yu HY; Hu FQ; Yuan H
    Int J Nanomedicine; 2013; 8():2859-69. PubMed ID: 23990715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan/VEGF-sIRNA nanoparticle for gene silencing.
    Yang Y; Liu X; Zhang D; Yu W; Lv G; Xie H; Zheng J; Ma X
    J Control Release; 2011 Nov; 152 Suppl 1():e160-1. PubMed ID: 22195822
    [No Abstract]   [Full Text] [Related]  

  • 15. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.
    Jiang HL; Xu CX; Kim YK; Arote R; Jere D; Lim HT; Cho MH; Cho CS
    Biomaterials; 2009 Oct; 30(29):5844-52. PubMed ID: 19640582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ternary nanoparticles of anionic lipid nanoparticles/protamine/DNA for gene delivery.
    Yuan H; Zhang W; Du YZ; Hu FQ
    Int J Pharm; 2010 Jun; 392(1-2):224-31. PubMed ID: 20230883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear localization signal peptides enhance transfection efficiency of chitosan/DNA complexes.
    Opanasopit P; Rojanarata T; Apirakaramwong A; Ngawhirunpat T; Ruktanonchai U
    Int J Pharm; 2009 Dec; 382(1-2):291-5. PubMed ID: 19716869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs.
    Gu W; Payne E; Sun S; Burgess M; McMillan NA
    Cancer Gene Ther; 2011 Mar; 18(3):219-27. PubMed ID: 21102424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.
    Cashman SM; Bowman L; Christofferson J; Kumar-Singh R
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3496-504. PubMed ID: 16877421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
    Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
    Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.